Cervical Cancer Clinical Trials

A listing of Cervical Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 50 clinical trials
A Multicenter, Open-label, Phase 2 Basket Study of MK-7684A, a Co-formation of Vibostolimab (MK-7684) With Pembrolizumab (MK-3475), With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors

-free survival in participants with cervical cancer.

adenocarcinoma of the gastroesophageal junction
breast cancer
docetaxel
mammogram
capecitabine
  • 1 views
  • 19 Sep, 2022
  • 64 locations
A Phase 1 Study of SGN-B6A in Advanced Solid Tumors

This trial will look at a drug called SGN-B6A to find out whether it is safe for people who have solid tumors. It will study SGN-B6A to find out what its side effects are. A side effect is anything the drug does besides treating cancer. It will also study whether …

solid tumour
breast cancer
ovarian cancer
cancer of the ovary
lung carcinoma
  • 179 views
  • 22 Sep, 2022
  • 12 locations
A Modular Phase I/IIa, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies (PETRA)

This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced solid tumors.

paclitaxel
cancer
chemotherapeutic agent
parp inhibitor
antineoplastic
  • 18 views
  • 21 Sep, 2022
  • 30 locations
A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects With Advanced Malignancies

This trial will look at a drug called SEA-TGT (also known as SGN-TGT) to find out whether it is safe for patients with solid tumors and lymphomas. It will study SEA-TGT to find out what its side effects are. A side effect is anything the drug does besides treating cancer. …

diffuse large b-cell lymphoma
solid tumour
prednisone
t-cell lymphoma
systemic therapy
  • 110 views
  • 21 Sep, 2022
  • 33 locations
A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations

This trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual (HER2 alterations) The solid tumors studied in this trial have either spread to other parts of the body (metastatic) or cannot be removed completely with surgery (unresectable). …

breast cancer
endocrine therapy
mammogram
erbb2
trastuzumab
  • 27 views
  • 21 Sep, 2022
  • 61 locations
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

carcinoma (temporarily closed to accrual 04/29/2020) Clear cell cervical cancer Esthenioneuroblastoma (closed to accrual) Endometrial carcinosarcoma (malignant mixed Mullerian

solid tumour
thyroiditis
bone metastases
angiosarcoma
lymphoma
  • 6651 views
  • 17 Sep, 2022
  • 753 locations
A Phase I, Open-label, Dose Escalation Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands

The primary purpose of this study is to find the recommended dose of LGK974 as a single agent and in combination with PDR001 that can be safely given to adult patients with selected solid malignancies that have progressed despite standard therapy or for which no effective standard therapy exists

BRAF
pdr001
mek inhibitor
systemic therapy
immunomodulators
  • 1231 views
  • 23 Sep, 2022
  • 13 locations
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

This is a phase II trial of combination therapy of pembrolizumab and lenvatinib in patients with locally advanced or metastatic cervical cancer that had failed first line of therapy. The

anticoagulant
aptt
neutrophil count
metastatic cervical cancer
growth factors
  • 0 views
  • 08 Aug, 2022
  • 2 locations
Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer (TIL)

A study that aimed to assess the safety and anti-tumor activity of C-TIL052A cell therapy in subjects with persistent, recurrent and/or metastatic cervical cancer.

metastatic cervical cancer
  • 0 views
  • 11 Aug, 2022
  • 2 locations
Evaluation of Resectable Cervical Carcinoma With PET/MRI

This trial studies how well positron emission tomography/magnetic resonance imaging (PET/MRI) scan works in checking patients with stage IA1-IB3 cervical cancer that can be removed by surgery

  • 0 views
  • 15 Sep, 2022
  • 1 location